CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.3433
-0.0293 (-7.86%)
At close: Sep 2, 2026, 4:00 PM EDT
0.3200
-0.0233 (-6.79%)
After-hours: Sep 2, 2026, 7:59 PM EDT
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $6.49 million as of September 2, 2026. Its market cap has decreased by -80.51% in one year.
Market Cap
6.49M
Enterprise Value
4.88M
1-Year Change
-80.51%
Ranking
Category
Stock Price
$0.34
ChartMarket Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $6.49M, a decrease of -78.79%. That is a compound annual growth rate of -16.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 5.40M | -69.83% |
| Dec 31, 2025 | 17.90M | -56.55% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
| Jan 31, 2018 | 30.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 7.67M |
| Alzamend Neuro | 7.67M |
| Acurx Pharmaceuticals | 7.64M |
| Ensysce Biosciences | 7.64M |
| Evogene | 7.51M |
| Ernexa Therapeutics | 7.46M |
| Creative Medical Technology Holdings | 7.45M |
| Skye Bioscience | 7.44M |